Search results for " market" in Articles / App Notes
Article
Is Not Using a CDMO Slowing Down Your Process Development?
Consider what process development capabilities you have versus what you could possibly gain from working with a CDMO to not only be successful, but also to improve your chances of getting to market …
Article
Approaches to Improve Efficiency in Biopharmaceutical Process Development
Click here to read the article >>
Time to experiment, time to clinic, and time to market are becoming even more important for developers and manufacturers of biopharmaceuticals. This a…
Article
Improving Capacity in DNA Plasmid Purification
Join Tony Hitchcock on May 6, 2020 to learn more about this critical market and how Cobra Biologics is working with Cytiva to develop a modern chromatography resin to help meet the demand.
Reg…
Article
The Future of Biopharma
When it comes to meeting unmet needs, biosimilars have a huge role to play, as they introduce competition to the market that can help to bring down the cost of expensive biopharmaceuticals. In the sec…
Article
Flexible Facilities for Viral Vector Manufacturing
“Speed to market is critical for most, if not all, biologics. This is quite relevant in the gene therapy segment as many gene therapies are qualifying for orphan drug status or fast track designation …
Article
Getting Ahead of the Game in Cell and Gene Therapy
Successes in the clinic have placed many cell and gene therapies on an accelerated route to market. But unless developers consider, at an early stage, how they might produce their product at scale, th…
Article
The Need for Advanced Process Modeling for New Therapeutic Biologics
Personalized medicines
Having a model-based approach is especially useful for personalized medicines, which typically target niche disease markets and small patient populations, but for which eac…
Article
Securing Today’s Biomanufacturing Supply Chain Using Transformative Supply
Though monoclonal antibodies are expected to continue dominating the market, a more diversified pipeline that includes, for example, DNA and RNA molecules and cell and gene therapies, is anticipated a…
Article
Best Practices for Selecting a Top-Quality Cell Line
As a result, the process of preparing them so they are safe and effective is multifaceted and complicated, according to Kris Simonyi, global marketing manager with Bio-Rad Laboratories. “One must conf…
Article
Methods Accelerate Biosimilar Analysis
…arifying regulatory requirements and expectations for demonstration of biosimilarity in support of a marketing application (1).
As the foundation in the development of biosimilars is the analy…